Aberrant expression of ADAM9 in ovarian cancer and its clinical significance

BACKGROUND: The oncogene a disintegrin and metalloproteinase 9 (ADAM9) was up‐regulated in ovarian cancer tissues, and the present study aims to explore the potential diagnostic and prognostic value of ADAM9 in ovarian cancer (OC). METHODS: A total of 30 paired fresh OC tumor tissues and the paired‐...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Ting, Yuan, Donglan, Lin, Mei, Zhu, Dandan, Xu, Ning, Wang, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7171348/
https://www.ncbi.nlm.nih.gov/pubmed/31793719
http://dx.doi.org/10.1002/jcla.23136

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7171348/
https://www.ncbi.nlm.nih.gov/pubmed/31793719
http://dx.doi.org/10.1002/jcla.23136

Ejemplares similares